
Mayo Clinic's study spanning 2010-2020 assesses 282 Microscopic Colitis patients treated with Bile Acid Sequestrants (BAS). Two-thirds exhibit partial or complete response, with no significant difference based on BAS type or combination with other medications. Bile acid testing, conducted in 31.9% of cases, showed a 56.7% positive rate. Recurrence after BAS discontinuation occurred in 41.6% at a median of 21 weeks. The study highlights BAS efficacy, emphasizing the need for further research on their role and bile acid malabsorption in Microscopic Colitis.
Like
Save
Share